These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30362844)

  • 1. Personalized vaccination against ovarian cancer: what are the possibilities?
    Tanyi JL; George E
    Expert Rev Vaccines; 2018 Nov; 17(11):955-958. PubMed ID: 30362844
    [No Abstract]   [Full Text] [Related]  

  • 2. Personalized neoantigen vaccines: A new approach to cancer immunotherapy.
    Aldous AR; Dong JZ
    Bioorg Med Chem; 2018 Jun; 26(10):2842-2849. PubMed ID: 29111369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer neoantigen: Boosting immunotherapy.
    Xu P; Luo H; Kong Y; Lai WF; Cui L; Zhu X
    Biomed Pharmacother; 2020 Nov; 131():110640. PubMed ID: 32836075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer vaccine candidate DPX-Survivac: positive interim results from phase 1.
    Riedmann EM
    Hum Vaccin Immunother; 2012 Dec; 8(12):1743. PubMed ID: 23980265
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccine-based clinical trials in ovarian cancer.
    Leffers N; Daemen T; Boezen HM; Melief KJ; Nijman HW
    Expert Rev Vaccines; 2011 Jun; 10(6):775-84. PubMed ID: 21692699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized cancer neoantigen vaccines come of age.
    Chu Y; Liu Q; Wei J; Liu B
    Theranostics; 2018; 8(15):4238-4246. PubMed ID: 30128050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for a personalized peptide vaccine against lung cancer.
    Nakahara Y; Kouro T; Igarashi Y; Kawahara M; Sasada T
    Expert Rev Vaccines; 2019 Jul; 18(7):703-709. PubMed ID: 31225971
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospects and challenges for immunotherapy of ovarian cancer--what can we learn from the tumor microenvironment?
    Chiriva-Internati M; Cobos E; Cannon MJ
    Int Rev Immunol; 2011; 30(2-3):67-70. PubMed ID: 21557634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized peptide vaccines and their relation to other therapies in urological cancer.
    Kimura T; Egawa S; Uemura H
    Nat Rev Urol; 2017 Aug; 14(8):501-510. PubMed ID: 28561807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding dendritic cell immunotherapy in ovarian cancer.
    Drakes ML; Stiff PJ
    Expert Rev Anticancer Ther; 2016 Jun; 16(6):643-52. PubMed ID: 27078511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for ovarian cancer: what's next?
    Kandalaft LE; Powell DJ; Singh N; Coukos G
    J Clin Oncol; 2011 Mar; 29(7):925-33. PubMed ID: 21079136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine.
    Wu D; Wang J; Cai Y; Ren M; Zhang Y; Shi F; Zhao F; He X; Pan M; Yan C; Dou J
    J Ovarian Res; 2015 Oct; 8():68. PubMed ID: 26497895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile: ImmunoCellular Therapeutics Ltd.
    Yu JS
    Hum Vaccin Immunother; 2012 Dec; 8(12):1745. PubMed ID: 23817320
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy at large: the road to personalized cancer vaccines.
    Vonderheide RH; Nathanson KL
    Nat Med; 2013 Sep; 19(9):1098-100. PubMed ID: 24013748
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospect and progress of personalized peptide vaccinations for advanced cancers.
    Sakamoto S; Noguchi M; Yamada A; Itoh K; Sasada T
    Expert Opin Biol Ther; 2016; 16(5):689-98. PubMed ID: 26938083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized vaccines for cancer immunotherapy.
    Sahin U; Türeci Ö
    Science; 2018 Mar; 359(6382):1355-1360. PubMed ID: 29567706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic cancer vaccines: From initial findings to prospects.
    Song Q; Zhang CD; Wu XH
    Immunol Lett; 2018 Apr; 196():11-21. PubMed ID: 29407608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preface.
    Tainsky MA; Morris RT
    Cancer Metastasis Rev; 2015 Mar; 34(1):3. PubMed ID: 25648358
    [No Abstract]   [Full Text] [Related]  

  • 19. General keynote: vaccine strategies for the therapy of ovarian cancer.
    Hodge JW; Tsang KY; Poole DJ; Schlom J
    Gynecol Oncol; 2003 Jan; 88(1 Pt 2):S97-104; discussion S110-3. PubMed ID: 12586096
    [No Abstract]   [Full Text] [Related]  

  • 20. Understanding the cross-talk between ovarian tumors and immune cells: mechanisms for effective immunotherapies.
    Chiriva-Internati M; Mirandola L; Kast WM; Jenkins MR; Cobos E; Cannon MJ
    Int Rev Immunol; 2011; 30(2-3):71-86. PubMed ID: 21557635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.